
Postpartum Hormones and Mood: What's Actually Happening in Your Brain
Written by
Phoenix Health Editorial Team
Expert health information, double-checked for accuracy and written to be helpful.
Last updated
Written by
Phoenix Health Editorial Team
Expert health information, double-checked for accuracy and written to be helpful.
Last updated
You knew you might feel emotional after birth. Everyone said that. Baby blues are normal, your OB told you. You'll probably feel weepy for a few days. What nobody explained is that postpartum hormones would crash from their lifetime peak to near-zero within 48 hours of delivery. Not drop. Crash. Estrogen and progesterone, which had been running at 10 to 100 times their baseline during pregnancy, would plummet faster than at any other point in human physiology. What you're feeling is not a personality flaw or a failure to cope. It is a measurable, predictable neurochemical event, and the FDA now has medications specifically designed to reverse it.
What pregnancy does to your brain
For nine months, your brain ran on hormone levels it had never encountered before. The placenta produced estrogen and progesterone in massive quantities, driving circulating levels to 10 to 100 times their normal non-pregnant baseline. This was not a small fluctuation. It was a sustained endocrine saturation that restructured how your brain worked at the receptor level.
Estrogen acts as a master regulator of mood chemistry. It boosts serotonin synthesis, suppresses the enzyme that destroys serotonin, and stimulates dopamine receptors throughout the brain. It also helps regulate your cortisol response. Flood the brain with estrogen for 40 weeks and it adapts: receptors multiply, pathways recalibrate, and the whole system rebuilds itself around that saturated environment.
Progesterone has a second effect that most people are never told about. Inside the brain, it converts into a compound called allopregnanolone, which functions as the brain's own sedative. Allopregnanolone binds to GABA receptors, the same receptors targeted by anti-anxiety medications, calming neural excitability and damping the stress response. As progesterone rose through pregnancy, allopregnanolone rose in step. Many people describe feeling surprisingly emotionally stable during the second and third trimesters. That stability is neurochemical. The brain was running on a sustained, endogenous tranquilizer.
The hormonal cliff
Within 24 to 72 hours of delivery, both estrogen and progesterone drop from their lifetime high to nearly zero. The placenta is gone, and it was the source. There is nothing gradual about it.
For comparison: menopause involves a decline in estrogen that plays out over years, giving the brain time to adjust receptor density and develop a new equilibrium. The postpartum drop happens in hours. There is no physiological parallel to this in human life. It is the most extreme hormonal withdrawal the human body undergoes.
Four neurochemical failures happen in rapid sequence. First, estrogen withdrawal spikes monoamine oxidase, the enzyme that destroys serotonin, while simultaneously cutting off the enzyme needed to make new serotonin. Serotonin levels crash. Second, the extra dopamine D2 receptors that grew in response to pregnancy estrogen are left without input. The dopamine system goes quiet, affecting motivation, focus, and the ability to feel reward. Third, with progesterone gone, allopregnanolone synthesis stops entirely. The brain's inhibitory system loses its primary modulator, and neural circuits that were heavily dampened begin firing without restraint. Fourth, the stress-response axis, which estrogen had been regulating for 40 weeks, loses that regulation. Cortisol stays elevated for roughly the first 12 weeks postpartum, locking the nervous system in a persistent physiological alert state.
Why anxiety and depression feel chemically different
Postpartum depression and postpartum anxiety are often grouped together, but they have different neurochemical drivers. The distinction matters because the underlying mechanisms point to different biology, and increasingly, to different treatments.
The depressive symptoms trace mainly to the serotonin and dopamine crash from estrogen withdrawal. The brain's reward and emotion-regulation systems go quiet. Anhedonia (the inability to feel pleasure), tearfulness, heavy brain fog, physical lethargy, and the flattened affect characteristic of postpartum depression all come from this pathway.
The anxiety symptoms trace to a different mechanism: allopregnanolone withdrawal. Without the brain's endogenous GABA modulator, cortical excitability spikes. The brain cannot slow its firing rate to achieve rest. This is why postpartum anxiety has a specific, paradoxical quality: exhausted and wired at the same time. Hyperarousal, panic, intrusive thoughts, and the inability to sleep even when the baby is down and the house is quiet are all neurobiological in origin. They are not a failure of psychological coping. They are cortical hyperexcitability from GABAergic withdrawal.
Both can coexist, and often do. Understanding which mechanism is dominant matters for treatment, because the targeted medications now available work by restoring different systems.
Postpartum thyroiditis: the mimic most providers miss
Between 5% and 10% of postpartum people develop an autoimmune condition called postpartum thyroiditis. It is chronically underdiagnosed because its symptoms mimic postpartum anxiety and depression so closely that clinicians frequently misattribute them. And the standard screening approach, a TSH check at the 6-week visit, catches only 53% of cases. The condition is documented thoroughly in NCBI's StatPearls on Postpartum Thyroiditis, and the American Thyroid Association publishes patient-facing guidance on what to watch for.
The mechanism is immune rebound. During pregnancy, the immune system suppresses itself to tolerate the fetus. After delivery, it reconstitutes aggressively, and in susceptible individuals this triggers an autoimmune attack on the thyroid. Thyroid peroxidase antibodies, already present in 6% to 11% of women before pregnancy, drive the destruction.
Postpartum thyroiditis is classically biphasic. In months 1 to 4, the destruction of thyroid tissue causes stored hormones to dump into the bloodstream. The resulting hyperthyroid state produces palpitations, severe anxiety, insomnia, heat intolerance, and irritability. This is routinely misdiagnosed as postpartum anxiety. Then around months 4 to 8, those stores are depleted and the damaged gland can't produce new hormone. The hypothyroid phase brings crushing fatigue, brain fog, depression, cold intolerance, and weight gain. This is routinely misdiagnosed as late-onset postpartum depression.
The test that would catch it, anti-thyroid peroxidase (anti-TPO) antibodies, is almost never ordered at the 6-week visit. Between 20% and 50% of people with postpartum thyroiditis go on to develop permanent hypothyroidism requiring lifelong medication. A condition this common deserves routine screening. It rarely gets it.
PMDD and ADHD: when the cliff hits harder
For some people, the postpartum hormonal drop doesn't just land hard. It lands as a clinical crisis. Two groups are at elevated biological risk and often don't know it going in.
People with a history of premenstrual dysphoric disorder (PMDD) are approximately three times more likely to develop postpartum depression. PMDD is not about abnormal hormone levels. It's about an abnormal neurological response to normal hormone fluctuations. The brain is inherently more sensitive to rising and falling estrogen and progesterone. When the postpartum drop arrives, that sensitivity means the crash lands harder and faster than it does for people without this history.
People with ADHD face a distinct version of the same problem. High estrogen during pregnancy stimulates dopamine D2 receptors, often producing a period of unusual cognitive clarity. ADHD symptoms can quiet down or disappear entirely. Then estrogen crashes, the dopamine scaffolding disappears, and underlying ADHD is unmasked or severely worsened. Stimulant medications may also become less effective as estrogen-dependent receptor dynamics shift. The perinatal ADHD guide covers this in full.
There is also a second cliff that often goes unrecognized: weaning. When breastfeeding ends, prolactin and oxytocin, which have been providing genuine anxiolytic and mood-stabilizing effects throughout lactation, drop significantly. This can trigger post-weaning depression: sadness, irritability, grief, and anxiety that arrive specifically when nursing stops, not only in the immediate postpartum period. Mothers who don't exclusively breastfeed are approximately 1.89 times more likely to develop postpartum depression, which reflects the loss of that lactogenic hormone support.
The medication breakthrough that proved the biology
For decades, postpartum depression was treated primarily with SSRIs, which target the serotonin system and take 4 to 8 weeks to show effect. In 2019, a different approach changed the picture. The FDA approved brexanolone (Zulresso), a synthetic form of allopregnanolone delivered as a 60-hour intravenous infusion in a monitored setting. By supplying the brain with exactly the neurosteroid it lost when progesterone crashed, brexanolone restored GABAergic inhibition directly. Patients experienced remission of symptoms within hours, not weeks. The MGH Center for Women's Mental Health has documented this clinical shift extensively, along with the evidence base for oral options.
In 2023, the FDA approved zuranolone (Zurzuvae), an oral formulation that works by the same mechanism but can be taken at home as a once-daily pill for 14 days. Measurable symptom improvement in clinical trials was seen by day 3. Not weeks. Days. Because the drug targets the root cause, the GABA deficit, rather than downstream mood effects.
This pharmacological history matters beyond the treatment question itself. The fact that restoring allopregnanolone directly resolves postpartum depression symptoms proves the biological mechanism. This is not a condition caused by character, resilience, or willingness to seek help. It is a predictable neurochemical withdrawal with measurable, reversible biology.
What a real workup looks like
The standard 6-week postpartum checkup catches almost none of this. A TSH test, a depression screening, a blood pressure check, and a pelvic exam do not evaluate the neuroendocrine drivers of postpartum mental health. If you're experiencing mood symptoms, anxiety, brain fog, or fatigue, here is what a thorough workup should include.
For thyroid: anti-TPO antibodies plus free T3 and free T4, not just TSH. The anti-TPO test identifies the autoimmune attack before it reaches its most symptomatic phase. TSH alone at 6 weeks misses roughly half of all cases. If any result is abnormal, or if symptoms persist, repeat testing at 3 to 4 months and again at 6 months. The clinical target for TSH in optimal neurological recovery is below 2.5 mIU/L, not merely within the broad normal reference range.
For hormonal recovery: estradiol and progesterone levels show whether the ovaries have resumed function or whether the patient is in a prolonged hypoestrogenic state, which is common during extended lactation. Prolactin is worth measuring if there are significant supply issues or marked post-weaning symptoms.
For nutritional cofactors: ferritin, vitamin D, B12, folate, and magnesium. The brain cannot synthesize serotonin or dopamine without these raw materials, regardless of how much the hormones have recovered. Pregnancy depletes all of them. Treating the hormonal picture without checking the nutritional foundation leaves the recovery incomplete.
Biology doesn't resolve by white-knuckling it through. If you ask your provider for this workup and meet resistance, that's useful information. Providers who specialize in perinatal mental health understand what the full picture requires.
A perinatal therapist does more than talk therapy. They understand the endocrine reality behind postpartum mental health, and many work in close coordination with prescribers who can evaluate the medical picture alongside the emotional one. Most Phoenix Health therapists hold PMH-C certification from Postpartum Support International, the clinical credential specifically for perinatal care. You don't have to explain why your brain feels like this. They already know.
Frequently Asked Questions
- After delivery, the placenta, which was producing the bulk of pregnancy hormones, is gone. Estrogen and progesterone, which had been running at 10 to 100 times their baseline for nine months, drop to near-zero within 24 to 72 hours. There is no gradual taper. The brain, which had structurally adapted to those saturated hormone levels over 40 weeks, suddenly has none of that chemical support. This is not a design flaw. It is the mechanism that allows the body to shift from pregnancy maintenance to postpartum physiology. But it is also the biological driver of the baby blues, and in some people, of postpartum depression and anxiety. The velocity of the drop is what makes it so disruptive.
- Postpartum thyroiditis is an autoimmune inflammation of the thyroid gland that develops in 5% to 10% of postpartum people, usually within the first year after delivery. It typically unfolds in two phases. The first, occurring around months 1 to 4, involves hyperthyroidism: palpitations, anxiety, insomnia, and irritability caused by stored thyroid hormones leaking into the blood as the gland is attacked. The second, around months 4 to 8, involves hypothyroidism: fatigue, depression, brain fog, and cold intolerance as the gland's stores are depleted and damaged tissue can't produce new hormone. Both phases are frequently misdiagnosed as postpartum anxiety or depression. The standard TSH test at 6 weeks catches only 53% of cases. The key missing test is anti-thyroid peroxidase (anti-TPO) antibodies. If you're experiencing mood or cognitive symptoms that aren't responding to standard care, ask your provider to check anti-TPO antibodies plus free T3 and free T4.
- Both are FDA-approved medications for postpartum depression that target the allopregnanolone mechanism directly. Allopregnanolone is a compound the brain produces from progesterone that acts as the brain's natural sedative. When progesterone crashes after delivery, allopregnanolone disappears with it, contributing to the hyperarousal and emotional dysregulation of postpartum anxiety and depression. Brexanolone (Zulresso), approved in 2019, is a synthetic allopregnanolone delivered as a 60-hour IV infusion in a monitored medical setting. Zuranolone (Zurzuvae), approved in 2023, is taken as a pill at home for 14 days. Both restore the GABA-regulating function that was lost when progesterone dropped. In clinical trials, zuranolone produced measurable symptom improvement by day 3. Unlike SSRIs, which take weeks to work by adjusting the serotonin system, these medications target the root hormonal mechanism.
- Yes, significantly. People with a history of premenstrual dysphoric disorder (PMDD) are approximately three times more likely to develop postpartum depression than those without it. PMDD is characterized by an abnormal neurological sensitivity to fluctuations in estrogen and progesterone, not by abnormal hormone levels themselves. When the postpartum hormonal drop occurs, that heightened sensitivity produces a more severe response than it does in people without this history. This is clinically relevant information for your care team before and after delivery. It doesn't make postpartum depression inevitable, but it does mean proactive monitoring and a lower threshold for early treatment are warranted.
- Yes, through two distinct mechanisms. During lactation, prolactin and oxytocin provide genuine anxiolytic and mood-stabilizing effects. Mothers who don't exclusively breastfeed are approximately 1.89 times more likely to develop postpartum depression, which reflects the absence of this lactogenic hormone support. When breastfeeding ends (weaning), prolactin and oxytocin drop, which can trigger post-weaning depression: sadness, irritability, anxiety, and grief that arrive specifically when nursing stops. This is most common with abrupt weaning. It doesn't mean breastfeeding is required for mental health, and for some people breastfeeding difficulties create their own significant stress. But the hormonal reality of lactation, and of weaning, is part of the full postpartum picture.
Ready to get support for Postpartum Depression?
Our PMH-C certified therapists specialize in Postpartum Depression and can typically see you within a week.
Not ready to book? Dr. Emily writes a short email series on Postpartum Depression, honest and practical, from a PMH-C therapist who's been through it herself.
No spam · Unsubscribe anytime